Cargando…

Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock

BACKGROUND: In patients with vasodilatory shock, plasma concentrations of angiotensin I (ANG I) and II (ANG II) and their ratio may reflect differences in the response to severe vasodilation, provide novel insights into its biology, and predict clinical outcomes. The objective of these protocol pres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bellomo, Rinaldo, Wunderink, Richard G., Szerlip, Harold, English, Shane W., Busse, Laurence W., Deane, Adam M., Khanna, Ashish K., McCurdy, Michael T., Ostermann, Marlies, Young, Paul J., Handisides, Damian R., Chawla, Lakhmir S., Tidmarsh, George F., Albertson, Timothy E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006163/ https://www.ncbi.nlm.nih.gov/pubmed/32028998 http://dx.doi.org/10.1186/s13054-020-2733-x

Ejemplares similares

Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial
por: Bellomo, Rinaldo, et al.
Publicado: (2020)

Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial
por: Ham, Kealy R., et al.
Publicado: (2019)

Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II
por: Tumlin, James A., et al.
Publicado: (2018)

Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial
por: Wieruszewski, Patrick M., et al.
Publicado: (2023)

Angiotensin converting enzyme defects in shock: implications for future therapy
por: Chawla, Lakhmir S., et al.
Publicado: (2018)

Angiotensin II: a new therapeutic option for vasodilatory shock
por: Bussard, Rachel L, et al.
Publicado: (2018)

The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature
por: Busse, Laurence W., et al.
Publicado: (2017)

Synthetic Human Angiotensin II in Pediatric Patients With Vasodilatory Shock: A Report on Two Patients
por: Bailey, Dwight M., et al.
Publicado: (2019)

Clinical Experience With IV Angiotensin II Administration: A Systematic Review of Safety
por: Busse, Laurence W., et al.
Publicado: (2017)

Angiotensin in Critical Care
por: Hall, Anna, et al.
Publicado: (2018)

COVID-19 and the RAAS—a potential role for angiotensin II?
por: Busse, Laurence W., et al.
Publicado: (2020)

Why the renin–angiotensin–aldosterone system (RAAS) in critically ill patients can no longer be ignored
por: Zarbock, Alexander, et al.
Publicado: (2021)

The use of angiotensin II in distributive shock
por: Chawla, Lakhmir S., et al.
Publicado: (2016)

Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series
por: Zangrillo, Alberto, et al.
Publicado: (2020)

Broad spectrum vasopressors: a new approach to the initial management of septic shock?
por: Chawla, Lakhmir S., et al.
Publicado: (2019)

Angiotensin II in vasodilatory shock: lights and shadows
por: Antonucci, Elio, et al.
Publicado: (2017)

Angiotensin II for the treatment of vasodilatory shock: enough data to consider angiotensin II safe?
por: Buchtele, Nina, et al.
Publicado: (2018)

Utilization of Synthetic Human Angiotensin II for Catecholamine-Resistant Vasodilatory Shock in Critically Ill Children: A Single-Center Retrospective Case Series
por: Tezel, Oguzhan, et al.
Publicado: (2023)

Catecholamine-induced Ischemic Necrosis of the Hand
por: Bostick, David S., et al.
Publicado: (2017)

Angiotensin in ECMO patients with refractory shock
por: Ostermann, Marlies, et al.
Publicado: (2018)

How Effective is Angiotensin II in Decreasing Mortality of Vasodilatory Shock? A Systematic Review
por: Semedi, Bambang Pujo, et al.
Publicado: (2023)

Reply to Picod et al.: Alteration of the Renin–Angiotensin–Aldosterone System in Shock: Role of the Dipeptidyl Peptidase 3
por: Chawla, Lakhmir S.
Publicado: (2021)

Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study
por: Chawla, Lakhmir S, et al.
Publicado: (2014)

Effect of renal denervation on catecholamines and the renin–angiotensin–aldosterone system
por: Feyz, Lida, et al.
Publicado: (2020)

Angiotensin II infusion in COVID‐19: An international, multicenter, registry‐based study
por: Serpa Neto, Ary, et al.
Publicado: (2022)

Angiotensin II in experimental hyperdynamic sepsis
por: Wan, Li, et al.
Publicado: (2009)

VASOPRESSOR-RESISTANT HYPOTENSION, COMBINATION VASOPRESSOR THERAPY, AND SHOCK PHENOTYPES IN CRITICALLY ILL ADULTS WITH VASODILATORY SHOCK
por: Priyanka, Priyanka, et al.
Publicado: (2022)

Physiologic Response to Angiotensin II Treatment for Coronavirus Disease 2019–Induced Vasodilatory Shock: A Retrospective Matched Cohort Study
por: Leisman, Daniel E., et al.
Publicado: (2020)

Endogenous angiotensins and catecholamines do not reduce skin blood flow or prevent hypotension in preterm piglets
por: Eiby, Yvonne A., et al.
Publicado: (2014)

The alternative renin–angiotensin system in critically ill patients: pathophysiology and therapeutic implications
por: Garcia, Bruno, et al.
Publicado: (2023)

Rethinking Vasopressor Education: The Need to Avoid Teaching the Bare Minimum
por: McCurdy, Michael T., et al.
Publicado: (2023)

Angiotensin II - A Brief Review and Role in Severe SARS-COV-2 Sepsis
por: Carà, Gianmarco A., et al.
Publicado: (2022)

Angiotensin-converting enzyme 2 and new insights into the renin–angiotensin system
por: Lambert, Daniel W., et al.
Publicado: (2008)

Gene Expression Scoring of Immune Activity Levels for Precision Use of Hydrocortisone in Vasodilatory Shock
por: Yao, Lijing, et al.
Publicado: (2022)

Angiotensin II may be useful for the treatment of hypotension in distributive shock, but a safe and efficacious dose is unknown
por: Busse, LW, et al.
Publicado: (2014)

Angiotensin-(1-7), Angiotensin-Converting Enzyme 2, and New Components of the Renin Angiotensin System
por: Trask, Aaron J., et al.
Publicado: (2009)

Angiotensin AT(1) – α(2C)-Adrenoceptor Interaction Disturbs α(2A)-auto-Inhibition of Catecholamine Release in Hypertensive Rats
por: Berg, Torill
Publicado: (2013)

Angiotensin II stimulates sympathetic neurotransmission to adipose tissue
por: King, Victoria L, et al.
Publicado: (2013)

Newer Insights into the Biochemical Physiology of the Renin–Angiotensin System: Role of Angiotensin-(1-7), Angiotensin Converting Enzyme 2, and Angiotensin-(1-12)
por: Ferrario, Carlos M., et al.
Publicado: (2009)

Retinal angiotensin II and angiotensin-(1-7) response to hyperglycemia and an intervention with captopril
por: Senanayake, Preenie deS, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6hmglqmjs77f83levjnmv620ei